~~<i id='BD012598A0'><strike id='BD012598A0'><tt id='BD012598A0'><pre id='BD012598A0'></pre></tt></strike></i>~~

00:00

00:00 00:00 LIVE

buffering

Replay

leisure time

Wikipedia

author：Wikipedia 2025-08-12 06:44:30 - browse：9

Alkermes shareholders voted Thursday to re-elect all of the drugmaker’s current directors, ending an acrimonious proxy fight with hedge fund Sarissa Capital Management, which had sought to seat three directors on the board.

At the company’s annual meeting, shareholders voted in favor of Alkermes’ proposal to retain all seven of the director nominees to the 11-person board.

The outcome is a setback for Sarissa, which owns 8.5% of Alkermes and is run by activist investor Alex Denner. Sarissa has accused Alkermes executives of mismanaging the business and destroying shareholder value.

Unlock this article by subscribing to STAT+ and enjoy your first 30 days free!

GET STARTED Log In

Previous article： Bright Health sells Medicare Advantage business to Molina
Next article： Lilly's Alzheimer's drug donanemab backed by FDA advisers

Wikipedia

leisure time

entertainment

explore

hotspot

Wikipedia

TheSouthernCaliforniaHospitalatHollywoodisseenintheHollywooddistrictofLosAngelesonFriday,Aug.4,2023.

WSS

Trump drops motion seeking removal of DA probing efforts to overturn 2020 election in Georgia

'Ancient DNA,' 23andMe reveal African American ancestries

Report captures long Covid’s disabling effects and policy challenges

Medical device trials still don't enroll enough women, study finds

Deposition: Sackler embraced plan to conceal OxyContin’s strength

TytoCare raises $49 million to build out AI

leisure time

Wikipedia

Wikipedia

Walensky prepares to leave CDC — and Congress — behind

Treeline, Josh Bilenker's next biotech, is cloaked in mystery

Wildfire smoke exposes gaps in outdoor worker protections

A cyberattack has disrupted hospitals and health care in several states

Food as medicine: CMS rules hamper 'prescribing' of fruits, veggies

Health care court cases: Humana, Sutter, Novant

In Memoriam: Notable people who died in 2023

TytoCare raises $49 million to build out AI

Duchenne breakthrough therapy leaves behind pioneering families

Mega Millions jackpot rises to record $1.55 billion for Tuesday's drawing

leisure time

My daughter's legacy lives on through her writing, phage therapy

Cancer thrives by mutating. But sometimes, a mutation leaves it vulnerable

Treeline, Josh Bilenker's next biotech, is cloaked in mystery

Moderna says combo Covid

Statins may not be needed by millions of people, study suggests

Curing rare childhood diseases will falter unless Congress steps up

entertainment

explore

hotspot

Wikipedia